annual FCF:
-$159.70M-$50.59M(-46.36%)Summary
- As of today (September 18, 2025), CLDX annual free cash flow is -$159.70 million, with the most recent change of -$50.59 million (-46.36%) on December 31, 2024.
- During the last 3 years, CLDX annual FCF has fallen by -$97.54 million (-156.92%).
- CLDX annual FCF is now -1003.48% below its all-time high of $17.68 million, reached on December 31, 2006.
Performance
CLDX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$44.73M+$9.90M(+18.13%)Summary
- As of today (September 18, 2025), CLDX quarterly free cash flow is -$44.73 million, with the most recent change of +$9.90 million (+18.13%) on June 1, 2025.
- Over the past year, CLDX quarterly FCF has dropped by -$15.13 million (-51.12%).
- CLDX quarterly FCF is now -222.89% below its all-time high of $36.40 million, reached on March 31, 2006.
Performance
CLDX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$188.48M-$15.13M(-8.73%)Summary
- As of today (September 18, 2025), CLDX TTM free cash flow is -$188.48 million, with the most recent change of -$15.13 million (-8.73%) on June 1, 2025.
- Over the past year, CLDX TTM FCF has dropped by -$65.55 million (-53.32%).
- CLDX TTM FCF is now -677.91% below its all-time high of $32.61 million, reached on March 31, 2006.
Performance
CLDX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
CLDX Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -46.4% | -51.1% | -53.3% |
| 3 y3 years | -156.9% | -95.2% | -137.2% |
| 5 y5 years | -238.7% | -268.7% | -302.2% |
CLDX Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -156.9% | at low | -133.6% | +19.9% | -137.2% | at low |
| 5 y | 5-year | -280.6% | at low | -719.6% | +19.9% | -349.2% | at low |
| alltime | all time | -1003.5% | at low | -222.9% | +19.9% | -677.9% | at low |
CLDX Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$44.73M(-18.1%) | -$188.48M(+8.7%) |
| Mar 2025 | - | -$54.64M(+64.4%) | -$173.35M(+8.6%) |
| Dec 2024 | -$159.70M(+46.4%) | -$33.23M(-40.5%) | -$159.70M(+0.0%) |
| Sep 2024 | - | -$55.88M(+88.8%) | -$159.66M(+29.9%) |
| Jun 2024 | - | -$29.60M(-27.8%) | -$122.93M(+1.6%) |
| Mar 2024 | - | -$40.98M(+23.4%) | -$120.94M(+10.8%) |
| Dec 2023 | -$109.11M(+3.4%) | -$33.20M(+73.4%) | -$109.11M(+11.4%) |
| Sep 2023 | - | -$19.15M(-30.6%) | -$97.91M(-14.3%) |
| Jun 2023 | - | -$27.61M(-5.3%) | -$114.29M(+4.3%) |
| Mar 2023 | - | -$29.15M(+32.5%) | -$109.61M(+3.8%) |
| Dec 2022 | -$105.56M(+69.8%) | -$22.00M(-38.1%) | -$105.56M(+7.2%) |
| Sep 2022 | - | -$35.54M(+55.1%) | -$98.44M(+23.9%) |
| Jun 2022 | - | -$22.92M(-8.7%) | -$79.46M(+15.8%) |
| Mar 2022 | - | -$25.11M(+68.8%) | -$68.62M(+10.4%) |
| Dec 2021 | -$62.16M(+48.2%) | -$14.88M(-10.1%) | -$62.16M(+17.9%) |
| Sep 2021 | - | -$16.56M(+37.1%) | -$52.74M(+9.4%) |
| Jun 2021 | - | -$12.07M(-35.3%) | -$48.20M(-0.1%) |
| Mar 2021 | - | -$18.65M(+241.7%) | -$48.26M(+15.0%) |
| Dec 2020 | -$41.96M(-11.0%) | -$5.46M(-54.6%) | -$41.96M(-11.9%) |
| Sep 2020 | - | -$12.02M(-0.9%) | -$47.60M(+1.6%) |
| Jun 2020 | - | -$12.13M(-1.7%) | -$46.86M(+1.7%) |
| Mar 2020 | - | -$12.35M(+11.2%) | -$46.07M(-2.3%) |
| Dec 2019 | -$47.15M(-38.0%) | -$11.11M(-1.6%) | -$47.15M(-8.7%) |
| Sep 2019 | - | -$11.28M(-0.5%) | -$51.63M(-5.8%) |
| Jun 2019 | - | -$11.34M(-15.5%) | -$54.80M(-10.4%) |
| Mar 2019 | - | -$13.42M(-13.9%) | -$61.19M(-19.5%) |
| Dec 2018 | -$76.05M(-25.2%) | -$15.59M(+7.9%) | -$76.05M(-5.1%) |
| Sep 2018 | - | -$14.45M(-18.5%) | -$80.17M(-11.3%) |
| Jun 2018 | - | -$17.73M(-37.3%) | -$90.36M(-4.2%) |
| Mar 2018 | - | -$28.28M(+43.5%) | -$94.36M(-7.2%) |
| Dec 2017 | -$101.72M(-12.1%) | -$19.71M(-20.0%) | -$101.72M(-1.2%) |
| Sep 2017 | - | -$24.64M(+13.4%) | -$103.00M(-0.1%) |
| Jun 2017 | - | -$21.73M(-39.0%) | -$103.11M(-11.1%) |
| Mar 2017 | - | -$35.64M(+69.8%) | -$115.98M(+0.2%) |
| Dec 2016 | -$115.79M(+11.6%) | -$20.99M(-15.2%) | -$115.79M(+6.3%) |
| Sep 2016 | - | -$24.76M(-28.4%) | -$108.95M(-3.9%) |
| Jun 2016 | - | -$34.60M(-2.4%) | -$113.34M(+7.9%) |
| Mar 2016 | - | -$35.44M(+150.4%) | -$105.06M(+1.2%) |
| Dec 2015 | -$103.76M(+0.3%) | -$14.15M(-51.5%) | -$103.76M(-7.3%) |
| Sep 2015 | - | -$29.15M(+10.8%) | -$111.99M(+1.7%) |
| Jun 2015 | - | -$26.31M(-23.0%) | -$110.10M(+4.3%) |
| Mar 2015 | - | -$34.15M(+52.6%) | -$105.55M(+2.0%) |
| Dec 2014 | -$103.47M(+43.9%) | -$22.38M(-17.9%) | -$103.47M(+5.2%) |
| Sep 2014 | - | -$27.26M(+25.3%) | -$98.36M(+9.9%) |
| Jun 2014 | - | -$21.75M(-32.2%) | -$89.54M(+3.4%) |
| Mar 2014 | - | -$32.07M(+85.6%) | -$86.60M(+20.5%) |
| Dec 2013 | -$71.89M(+43.5%) | -$17.27M(-6.3%) | -$71.89M(+5.6%) |
| Sep 2013 | - | -$18.44M(-2.0%) | -$68.05M(+12.2%) |
| Jun 2013 | - | -$18.81M(+8.4%) | -$60.63M(+12.6%) |
| Mar 2013 | - | -$17.36M(+29.2%) | -$53.85M(+7.5%) |
| Dec 2012 | -$50.09M(+38.5%) | -$13.44M(+22.0%) | -$50.09M(+8.6%) |
| Sep 2012 | - | -$11.02M(-8.5%) | -$46.13M(+6.5%) |
| Jun 2012 | - | -$12.04M(-11.4%) | -$43.29M(+6.4%) |
| Mar 2012 | - | -$13.60M(+43.5%) | -$40.70M(+12.5%) |
| Dec 2011 | -$36.17M(+11.4%) | -$9.48M(+15.8%) | -$36.17M(+9.1%) |
| Sep 2011 | - | -$8.18M(-13.4%) | -$33.14M(-0.3%) |
| Jun 2011 | - | -$9.45M(+4.2%) | -$33.24M(-2.8%) |
| Mar 2011 | - | -$9.07M(+40.5%) | -$34.21M(+5.4%) |
| Dec 2010 | -$32.47M(+6.8%) | -$6.45M(-22.0%) | -$32.47M(-12.1%) |
| Sep 2010 | - | -$8.28M(-20.6%) | -$36.95M(+7.7%) |
| Jun 2010 | - | -$10.42M(+42.3%) | -$34.29M(+7.1%) |
| Mar 2010 | - | -$7.32M(-33.0%) | -$32.03M(+5.4%) |
| Dec 2009 | -$30.40M(-279.1%) | -$10.93M(+94.5%) | -$30.40M(+67.0%) |
| Sep 2009 | - | -$5.62M(-31.1%) | -$18.20M(-18.9%) |
| Jun 2009 | - | -$8.16M(+43.3%) | -$22.44M(-243.8%) |
| Mar 2009 | - | -$5.69M(-548.7%) | $15.61M(-8.1%) |
| Dec 2008 | $16.98M(-169.9%) | $1.27M(-112.9%) | $16.98M(-721.5%) |
| Sep 2008 | - | -$9.86M(-133.0%) | -$2.73M(-144.1%) |
| Jun 2008 | - | $29.89M(-792.0%) | $6.19M(-123.8%) |
| Mar 2008 | - | -$4.32M(-76.6%) | -$26.07M(+7.4%) |
| Dec 2007 | -$24.28M | -$18.44M(+1874.2%) | -$24.28M(+109.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2007 | - | -$934.00K(-60.7%) | -$11.59M(-33.4%) |
| Jun 2007 | - | -$2.38M(-5.9%) | -$17.39M(-18.2%) |
| Mar 2007 | - | -$2.53M(-56.0%) | -$21.25M(-220.2%) |
| Dec 2006 | $17.68M(-315.8%) | -$5.75M(-14.7%) | $17.68M(-28.4%) |
| Sep 2006 | - | -$6.74M(+8.1%) | $24.67M(-7.3%) |
| Jun 2006 | - | -$6.24M(-117.1%) | $26.62M(-18.4%) |
| Mar 2006 | - | $36.40M(+2813.8%) | $32.61M(-498.1%) |
| Dec 2005 | -$8.19M(-41.5%) | $1.25M(-126.1%) | -$8.19M(-45.6%) |
| Sep 2005 | - | -$4.79M(+1859.2%) | -$15.07M(+4.3%) |
| Jun 2005 | - | -$244.60K(-94.4%) | -$14.45M(-9.7%) |
| Mar 2005 | - | -$4.40M(-21.8%) | -$16.00M(+14.3%) |
| Dec 2004 | -$14.00M(+17.2%) | -$5.63M(+35.0%) | -$14.00M(+21.2%) |
| Sep 2004 | - | -$4.17M(+131.4%) | -$11.55M(+13.8%) |
| Jun 2004 | - | -$1.80M(-25.0%) | -$10.15M(-8.6%) |
| Mar 2004 | - | -$2.40M(-24.6%) | -$11.11M(-7.0%) |
| Dec 2003 | -$11.95M(-31.7%) | -$3.18M(+15.0%) | -$11.95M(+20.5%) |
| Sep 2003 | - | -$2.77M(+0.2%) | -$9.92M(-20.4%) |
| Jun 2003 | - | -$2.76M(-14.7%) | -$12.47M(-17.4%) |
| Mar 2003 | - | -$3.24M(+181.5%) | -$15.09M(-13.8%) |
| Dec 2002 | -$17.50M(-19.0%) | -$1.15M(-78.4%) | -$17.50M(-20.5%) |
| Sep 2002 | - | -$5.32M(-1.3%) | -$22.01M(-3.1%) |
| Jun 2002 | - | -$5.39M(-4.6%) | -$22.72M(+3.8%) |
| Mar 2002 | - | -$5.65M(-0.2%) | -$21.89M(+1.3%) |
| Dec 2001 | -$21.60M(+341.6%) | -$5.66M(-6.2%) | -$21.60M(+32.2%) |
| Sep 2001 | - | -$6.03M(+32.2%) | -$16.34M(+26.2%) |
| Jun 2001 | - | -$4.56M(-14.9%) | -$12.95M(+14.3%) |
| Mar 2001 | - | -$5.36M(+1269.2%) | -$11.33M(+131.6%) |
| Dec 2000 | -$4.89M(-48.9%) | -$391.40K(-85.2%) | -$4.89M(-17.0%) |
| Sep 2000 | - | -$2.64M(-10.3%) | -$5.90M(+4.3%) |
| Jun 2000 | - | -$2.94M(-372.7%) | -$5.65M(+7.0%) |
| Mar 2000 | - | $1.08M(-177.3%) | -$5.29M(-42.7%) |
| Dec 1999 | -$9.57M(-0.0%) | -$1.40M(-41.7%) | -$9.23M(+2.4%) |
| Sep 1999 | - | -$2.39M(-6.9%) | -$9.01M(-14.1%) |
| Jun 1999 | - | -$2.57M(-10.2%) | -$10.48M(+3.6%) |
| Mar 1999 | - | -$2.86M(+143.7%) | -$10.12M(+10.7%) |
| Dec 1998 | -$9.57M(+17.4%) | -$1.18M(-69.6%) | -$9.15M(-9.2%) |
| Sep 1998 | - | -$3.87M(+75.1%) | -$10.07M(+22.8%) |
| Jun 1998 | - | -$2.21M(+17.0%) | -$8.20M(+8.0%) |
| Mar 1998 | - | -$1.89M(-10.0%) | -$7.59M(-2.7%) |
| Dec 1997 | -$8.15M(-21.0%) | -$2.10M(+5.0%) | -$7.80M(-4.9%) |
| Sep 1997 | - | -$2.00M(+25.0%) | -$8.20M(-2.4%) |
| Jun 1997 | - | -$1.60M(-23.8%) | -$8.40M(-3.4%) |
| Mar 1997 | - | -$2.10M(-16.0%) | -$8.70M(-15.5%) |
| Dec 1996 | -$10.32M(+5.9%) | -$2.50M(+13.6%) | -$10.30M(+51.5%) |
| Sep 1996 | - | -$2.20M(+15.8%) | -$6.80M(-20.9%) |
| Jun 1996 | - | -$1.90M(-48.6%) | -$8.60M(-5.5%) |
| Mar 1996 | - | -$3.70M(-470.0%) | -$9.10M(+7.1%) |
| Dec 1995 | -$9.74M(-6.2%) | $1.00M(-125.0%) | -$8.50M(-30.3%) |
| Sep 1995 | - | -$4.00M(+66.7%) | -$12.20M(+18.4%) |
| Jun 1995 | - | -$2.40M(-22.6%) | -$10.30M(-4.6%) |
| Mar 1995 | - | -$3.10M(+14.8%) | -$10.80M(+9.1%) |
| Dec 1994 | -$10.38M(+73.1%) | -$2.70M(+28.6%) | -$9.90M(+20.7%) |
| Sep 1994 | - | -$2.10M(-27.6%) | -$8.20M(+9.3%) |
| Jun 1994 | - | -$2.90M(+31.8%) | -$7.50M(+17.2%) |
| Mar 1994 | - | -$2.20M(+120.0%) | -$6.40M(+6.7%) |
| Dec 1993 | -$6.00M(+36.4%) | -$1.00M(-28.6%) | -$6.00M(+20.0%) |
| Sep 1993 | - | -$1.40M(-22.2%) | -$5.00M(-3.8%) |
| Jun 1993 | - | -$1.80M(0.0%) | -$5.20M(+8.3%) |
| Mar 1993 | - | -$1.80M(+12.5%) | -$4.80M(-5.9%) |
| Dec 1992 | -$4.40M(-2.2%) | - | - |
| Oct 1992 | - | -$1.60M(+14.3%) | -$5.10M(0.0%) |
| Jul 1992 | - | -$1.40M(-6.7%) | -$5.10M(+13.3%) |
| Apr 1992 | - | -$1.50M(+150.0%) | -$4.50M(+40.6%) |
| Apr 1992 | -$4.50M(+32.4%) | - | - |
| Jan 1992 | - | -$600.00K(-62.5%) | -$3.20M(-15.8%) |
| Oct 1991 | - | -$1.60M(+100.0%) | -$3.80M(0.0%) |
| Jul 1991 | - | -$800.00K(+300.0%) | -$3.80M(+11.8%) |
| Apr 1991 | -$3.40M(+142.9%) | -$200.00K(-83.3%) | -$3.40M(+6.3%) |
| Jan 1991 | - | -$1.20M(-25.0%) | -$3.20M(+60.0%) |
| Oct 1990 | - | -$1.60M(+300.0%) | -$2.00M(+400.0%) |
| Jul 1990 | - | -$400.00K | -$400.00K |
| Apr 1990 | -$1.40M | - | - |
FAQ
- What is Celldex Therapeutics, Inc. annual free cash flow?
- What is the all time high annual FCF for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. annual FCF year-on-year change?
- What is Celldex Therapeutics, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. quarterly FCF year-on-year change?
- What is Celldex Therapeutics, Inc. TTM free cash flow?
- What is the all time high TTM FCF for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. TTM FCF year-on-year change?
What is Celldex Therapeutics, Inc. annual free cash flow?
The current annual FCF of CLDX is -$159.70M
What is the all time high annual FCF for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high annual free cash flow is $17.68M
What is Celldex Therapeutics, Inc. annual FCF year-on-year change?
Over the past year, CLDX annual free cash flow has changed by -$50.59M (-46.36%)
What is Celldex Therapeutics, Inc. quarterly free cash flow?
The current quarterly FCF of CLDX is -$44.73M
What is the all time high quarterly FCF for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high quarterly free cash flow is $36.40M
What is Celldex Therapeutics, Inc. quarterly FCF year-on-year change?
Over the past year, CLDX quarterly free cash flow has changed by -$15.13M (-51.12%)
What is Celldex Therapeutics, Inc. TTM free cash flow?
The current TTM FCF of CLDX is -$188.48M
What is the all time high TTM FCF for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high TTM free cash flow is $32.61M
What is Celldex Therapeutics, Inc. TTM FCF year-on-year change?
Over the past year, CLDX TTM free cash flow has changed by -$65.55M (-53.32%)